Advanced search
Publication Cover
Future Microbiology Volume 4, 2009 - Issue 7
Submit an article Journal homepage
608
Views
0
CrossRef citations to date
0
Altmetric
Review

Pathogen recognition by DC-SIGN shapes adaptive immunity

Teunis BH Geijtenbeeka Department of Molecular Cell Biology & Immunology, VU University Medical Center, 1007 MC Amsterdam, The Netherlands and Center for Infection & Immunity Amsterdam and Center for Experimental & Molecular Medicine, Academic Medical Center, University of Amsterdam, PO Box 22660, 1100 DDAmsterdam, The Netherlands.Tel.: +31205666309 Fax: [email protected]View further author information
,
Jeroen den Dunnenb Department of Molecular Cell Biology & Histology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105AZ Amsterdam, The Netherlands. [email protected]View further author information
&
Sonja I Gringhuisc Department of Molecular Cell Biology & Immunology, VU University Medical Center, 1007 MC Amsterdam, The Netherlands andCenter for Infection & Immunity Amsterdam and Center for Experimental & Molecular Medicine, Academic Medical Center, University of Amsterdam, PO Box 22660, 1100DD Amsterdam, The Netherlands. [email protected]View further author information
Pages 879-890 | Published online: 01 Sep 2009

Bibliography

  • Banchereau J , SteinmanRM: Dendritic cells and the control of immunity.Nature392 , 245–252 (1998).
  • Liew FY : TH1 and TH2 cells: a historical perspective.Nat. Rev. Immunol.2 , 55–60 (2002).
  • Harrington LE , HattonRD, ManganPRet al.: Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.Nat. Immunol.6 , 1123–1132 (2005).
  • Park H , LiZX, YangXOet al.: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17.Nat. Immunol.6 , 1133–1141 (2005).
  • Mills KH : Induction, function and regulation of IL-17-producing T cells.Eur. J. Immunol.38 , 2636–2649 (2008).
  • Vignali DA , CollisonLW, WorkmanCJ: How regulatory T cells work.Nat. Rev. Immunol.8 , 523–532 (2008).
  • Murphy KM , ReinerSL: The lineage decisions of helper T cells.Nat. Rev. Immunol.2 , 933–944 (2002).
  • Mills KH : Regulatory T cells: friend or foe in immunity to infection?Nat. Rev. Immunol.4 , 841–855 (2004).
  • Janeway CA , MedzhitovR: Innate immune recognition.Annu. Rev. Immunol.20 , 197–216 (2002).
  • Medzhitov R : Recognition of microorganisms and activation of the immune response.Nature449 , 819–826 (2007).
  • Robinson MJ , SanchoD, SlackEC, LeibundGut-LandmannS, SousaCRE: Myeloid C-type lectins in innate immunity.Nat. Immunol.7 , 1258–1265 (2006).
  • van Vliet SJ , den Dunnen J, Gringhuis SI, Geijtenbeek TB, van Kooyk Y: Innate signaling and regulation of dendritic cell immunity. Curr. Opin. Immunol.19 , 435–440 (2007).
  • Iwasaki A , MedzhitovR: Toll-like receptor control of the adaptive immune responses.Nat. Immunol.5 , 987–995 (2004).
  • Kawai T , AkiraS: TLR signaling.Cell Death Differ.13 , 816–825 (2006).
  • Medzhitov R , JanewayCA Jr: Innate immunity: the virtues of a nonclonal system of recognition. Cell91 , 295–298 (1997).
  • Gringhuis SI , den Dunnen J, Litjens M et al.: C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-κB. Immunity26 , 605–616 (2007).
  • Geijtenbeek TB , van Vliet SJ, Koppel EA et al.: Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med.197 , 7–17 (2003).
  • Gantner BN , SimmonsRM, CanaveraSJ, AkiraS, UnderhillDM: Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2.J. Exp. Med.197 , 1107–1117 (2003).
  • Rogers NC , SlackEC, EdwardsADet al.: Syk-dependent cytokine induction by dectin-1 reveals a novel pattern recognition pathway for C type lectins.Immunity22 , 507–517 (2005).
  • Brown GD : Dectin-1, a signalling non-TLR pattern-recognition receptor.Nat. Rev. Immunol.6 , 33–43 (2006).
  • Figdor CG , van Kooyk Y, Adema GJ: C-type lectin receptors on dendritic cells and Langerhans cells. Nat. Rev. Immunol.2 , 77–84 (2002).
  • Drickamer K : C-type lectin-like domains.Curr. Opin. Struct. Biol.9 , 585–590 (1999).
  • Higashi N , MorikawaA, FujiokaKet al.: Human macrophage lectin specific for galactose/N-acetylgalactosamine is a marker for cells at an intermediate stage in their differentiation from monocytes into macrophages.Int. Immunol.14 , 545–554 (2002).
  • Higashi N , FujiokaK, Denda-NagaiKet al.: The macrophage C-type lectin specific for galactose/N-acetylgalactosamine is an endocytic receptor expressed on monocyte- derived immature dendritic cells.J. Biol. Chem.277 , 20686–20693 (2002).
  • Iobst ST , WormaldMR, WeisWI, DwekRA, DrickamerK: Binding of sugar ligands to Ca2+-dependent animal lectins. I. Analysis of mannose binding by site-directed mutagenesis and NMR.J. Biol. Chem.269 , 15505–15511 (1994).
  • Zelensky AN , GreadyJE: The C-type lectin-like domain superfamily.FEBS J.272 , 6179–6217 (2005).
  • Weis WI , TaylorME, DrickamerK: The C-type lectin superfamily in the immune system.Immunol. Rev.163 , 19–34 (1998).
  • Geijtenbeek TB , KrooshoopDJ, BleijsDAet al.: DC-SIGN–ICAM-2 interaction mediates dendritic cell trafficking.Nat. Immunol.1 , 353–357 (2000).
  • Geijtenbeek TB , TorensmaR, van Vliet SJ et al.: Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell100 , 575–585 (2000).
  • Steinman RM , BanchereauJ: Taking dendritic cells into medicine.Nature449 , 419–426 (2007).
  • Gringhuis SI , den Dunnen J, Litjens M et al.: Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-κB activation through Raf-1 and Syk. Nat. Immunol.10 , 203–213 (2009).
  • Engering A , van Vliet SJ, Geijtenbeek TB, van Kooyk Y: Subset of DC-SIGN+ dendritic cells in human blood transmits HIV-1 to T lymphocytes. Blood100 , 1780–1786 (2002).
  • Soilleux EJ , MorrisLS, LeslieGet al.: Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro.J. Leukoc. Biol.71 , 445–457 (2002).
  • Granelli-Piperno A , PritskerA, PackMet al.: Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction.J. Immunol.175 , 4265–4273 (2005).
  • Appelmelk BJ , Van Die I, van Vliet SJ et al.: Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J. Immunol.170 , 1635–1639 (2003).
  • Zhang P , SchwartzO, PantelicMet al.: DC-SIGN (CD209) recognition of Neisseria gonorrhoeae is circumvented by lipooligosaccharide variation.J. Leukoc. Biol.79 , 731–738 (2006).
  • Steeghs L , van Vliet SJ, Uronen-Hansson H et al.: Neisseria meningitidis expressing lgtB lipopolysaccharide targets DC-SIGN and modulates dendritic cell function. Cell Microbiol.8 , 316–325 (2006).
  • Zhang P , SnyderS, FengPet al.: Role of N- acetylglucosamine within core lipopolysaccharide of several species of Gram-negative bacteria in targeting the DC-SIGN (CD209).J. Immunol.177 , 4002–4011 (2006).
  • Bernhard OK , LaiJ, WilkinsonJ, SheilMM, CunninghamAL: Proteomic analysis of DC-SIGN on dendritic cells detects tetramers required for ligand binding but no association with CD4.J. Biol. Chem.279 , 51828–51835 (2004).
  • Mitchell DA , FaddenAJ, DrickamerK: A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands.J. Biol. Chem.276 , 28939–28945 (2001).
  • Geijtenbeek TB , KwonDS, TorensmaRet al.: DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells.Cell100 , 587–597 (2000).
  • van Kooyk Y , GeijtenbeekTB: DC-SIGN: escape mechanism for pathogens.Nat. Rev. Immunol.3 , 697–709 (2003).
  • de Witte L , AbtM, Schneider-SchauliesS, van Kooyk Y, Geijtenbeek TB: Measles virus targets DC-SIGN to enhance dendritic cell infection. J. Virol.80 , 3477–3486 (2006).
  • Tailleux L , SchwartzO, HerrmannJLet al.: DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells.J. Exp. Med.197 , 121–127 (2003).
  • Bergman MP , EngeringA, SmitsHHet al.: Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN.J. Exp. Med.200 , 979–990 (2004).
  • Cambi A , GijzenK, de Vries JM et al.: The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur. J. Immunol.33 , 532–538 (2003).
  • Smits HH , EngeringA, van der Kleij D et al.: Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J. Allergy Clin. Immunol.115 , 1260–1267 (2005).
  • Chatterjee D , KhooKH: Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects.Glycobiology8 , 113–120 (1998).
  • Sturgill-Koszycki S , SchlesingerPH, ChakrabortyPet al.: Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase.Science263 , 678–681 (1994).
  • Xu S , CooperA, Sturgill-KoszyckiSet al.: Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages.J. Immunol.153 , 2568–2578 (1994).
  • Gringhuis SI , den Dunnen DJ, Litjens M et al.: Carbohydrate-specific signaling through dynamic regulation of the DC-SIGN signalosome directs immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat. Immunol. (2009) (In Press).
  • Appelmelk BJ , ShiberuB, TrinksCet al.: Phase variation in Helicobacter pylori lipopolysaccharide.Infect. Immun.66 , 70–76 (1998).
  • Hodges A , SharrocksK, EdelmannMet al.: Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication.Nat. Immunol.8 , 569–577 (2007).
  • Smith AL , GaneshL, LeungKet al.: Leukocyte-specific protein 1 interacts with DC-SIGN and mediates transport of HIV to the proteasome in dendritic cells.J. Exp. Med.204 , 421–430 (2007).
  • Moris A , NobileC, BuseyneFet al.: DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation.Blood103 , 2648–2654 (2004).
  • Moris A , PajotA, BlanchetFet al.: Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer.Blood108 , 1643–1651 (2006).
  • Turville SG , SantosJJ, FrankIet al.: Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells.Blood103 , 2170–2179 (2004).
  • McDonald D , WuL, BohksSMet al.: Recruitment of HIV and its receptors to dendritic cell–T-cell junctions.Science300 , 1295–1297 (2003).
  • Halary F , AmaraA, Lortat-JacobHet al.: Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection.Immunity17 , 653–664 (2002).
  • Lozach PY , Lortat-JacobH, De Lacroix De Lavalette A et al.: DC-SIGN and L-SIGN are high-affinity binding receptors for hepatitis C virus glycoprotein E2. J. Biol. Chem.278(22) , 20358–20366 (2003).
  • de Jong MA , de Witte L, Bolmstedt A, van Kooyk Y, Geijtenbeek TB: Dendritic cells mediate herpes simplex virus infection and transmission through the C-type lectin DC-SIGN. J. Gen. Virol.89 , 2398–2409 (2008).
  • Tassaneetrithep B , BurgessTH, Granelli-PipernoAet al.: DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells.J. Exp. Med.197 , 823–829 (2003).
  • Alvarez CP , LasalaF, CarrilloJet al.: C-type lectins DC-SIGN and L-SIGN mediate cellular entry by ebola virus in cis and in trans.J. Virol.76 , 6841–6844 (2002).
  • Maeda N , NigouJ, HerrmannJLet al.: The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan.J. Biol. Chem.278 , 5513–5516 (2003).
  • Appelmelk BJ , den Dunnen J, Driessen NN et al.: The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium–host interaction. Cell Microbiol.10 , 930–944 (2008).
  • Pitarque S , HerrmannJL, DuteyratJLet al.: Deciphering the molecular bases of Mycobacterium tuberculosis binding to the lectin DC-SIGN reveals an underestimated complexity.Biochem. J.392 , 615–624 (2005).
  • Wellbrock C , KarasaridesM, MaraisR: The RAF proteins take centre stage.Nat. Rev. Mol. Cell Biol.5 , 875–885 (2004).
  • Lowell CA : Src-family kinases: rheostats of immune cell signaling.Mol. Immunol.41 , 631–643 (2004).
  • Baccarini M : Second nature: biological functions of the Raf-1 “kinase”.FEBS Lett.579 , 3271–3277 (2005).
  • Kolch W : Coordinating ERK/MAPK signalling through scaffolds and inhibitors.Nat. Rev. Mol. Cell Biol.6 , 827–837 (2005).
  • Caparros E , MunozP, Sierra-FilardiEet al.: DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production.Blood107 , 3950–3958 (2006).
  • Shreffler WG , CastroRR, KucukZYet al.: The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro.J. Immunol.177 , 3677–3685 (2006).
  • Shan M , KlassePJ, BanerjeeKet al.: HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.PLoS Pathog.3 , e169 (2007).
  • Ouaaz F , ArronJ, ZhengY, ChoiY, BegAA: Dendritic cell development and survival require distinct NF-κB subunits.Immunity16 , 257–270 (2002).
  • Hayden MS , GhoshS: Signaling to NF-κB.Genes Dev.18 , 2195–2224 (2004).
  • Chen LF , WilliamsSA, MuYJet al.: NF-κB RelA phosphorylation regulates RelA acetylation.Mol. Cell. Biol.25 , 7966–7975 (2005).
  • Chen LF , MuY, GreeneWC: Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-κB.EMBO J.21 , 6539–6548 (2002).
  • Chen LF , GreeneWC: Regulation of distinct biological activities of the NF-κB transcription factor complex by acetylation.J. Mol. Med.81 , 549–557 (2003).
  • Chen LF , FischleW, VerdinE, GreeneWC: Duration of nuclear NF-κB action regulated by reversible acetylation.Science293 , 1653–1657 (2001).
  • Netea MG , FerwerdaG, van der Graaf CAA, van der Meer JWM, Kullberg BJ: Recognition of fungal pathogens by Toll-like receptors. Curr. Pharm. Des.12 , 4195–4201 (2006).
  • Gross O , GewiesA, FingerKet al.: Card9 controls a non-TLR signalling pathway for innate antifungal immunity.Nature442 , 651–656 (2006).
  • LeibundGut-Landmann S , GrossO, RobinsonMJet al.: Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17.Nat. Immunol.8 , 630–638 (2007).
  • Bieback K , LienE, KlaggeIMet al.: Hemagglutinin protein of wild-type measles virus activates Toll-like receptor 2 signaling.J. Virol.76 , 8729–8736 (2002).
  • Marienfeld R , MayMJ, BerberichIet al.: RelB forms transcriptionally inactive complexes with RelA/p65.J. Biol. Chem.278 , 19852–19860 (2003).
  • Das S , BanerjeeG, DePonteKet al.: Salp25D, an Ixodes scapularis antioxidant, is 1 of 14 immunodominant antigens in engorged tick salivary glands.J. Infect. Dis.184 , 1056–1064 (2001).
  • Ramamoorthi N , NarasimhanS, PalUet al.: The Lyme disease agent exploits a tick protein to infect the mammalian host.Nature436 , 573–577 (2005).
  • Alexopoulou L , ThomasV, SchnareMet al.: Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice.Nat. Med.8 , 878–884 (2002).
  • Hirschfeld M , KirschningCJ, SchwandnerRet al.: Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2.J. Immunol.163 , 2382–2386 (1999).
  • Hovius JW , de Jong MA, den Dunnen J et al.: Salp15 binding to DC-SIGN inhibits cytokine expression by impairing both nucleosome remodeling and mRNA stabilization. PLoS Pathog.4 , e31 (2008).
  • Juncadella IJ , GargR, AnanthnarayananSK, YengoCM, AnguitaJ: T-cell signaling pathways inhibited by the tick saliva immunosuppressor, Salp15.FEMS Immunol. Med. Microbiol.49 , 433–438 (2007).
  • Lee B , LeslieG, SoilleuxEet al.: Cis expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor.J. Virol.75 , 12028–12038 (2001).
  • Takahara K , YashimaY, OmatsuYet al.: Functional comparison of the mouse DC-SIGN, SIGNR1, SIGNR3 and Langerin, C-type lectins.Int. Immunol.16 , 819–829 (2004).
  • Gramberg T , CaminschiI, WegeleA, HofmannH, PohlmannS: Evidence that multiple defects in murine DC-SIGN inhibit a functional interaction with pathogens.Virology345 , 482–491 (2006).
  • Schaefer M , ReilingN, FesslerCet al.: Decreased pathology and prolonged survival of human DC-SIGN transgenic mice during mycobacterial infection.J. Immunol.180 , 6836–6845 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.